<h1>India Approves 100% FDI in Medical Devices via Automatic Route, Aiming to Boost Investment and Technology.</h1> The Union Cabinet, led by the Prime Minister, approved amendments to the Foreign Direct Investment (FDI) policy in the pharmaceutical sector to specifically address medical devices. Previously, FDI up to 100% was allowed in pharmaceuticals under certain conditions, with greenfield projects on the automatic route and brownfield projects requiring government approval. Medical devices, categorized separately from pharmaceuticals, will now allow 100% FDI under the automatic route, exempting them from existing conditions like the non-compete clause. This change aims to boost investment in the medical devices sector, which is currently import-dependent and lacks sufficient capital and technology.